Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wade

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Nature Communications|August 18, 2024
CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflictsLaura Curti, Sara Rohban, Nicola Bianchi, et al.
Molecular Carcinogenesis|August 28, 2015
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor developmentCassandra J Adams, Jennifer S Yu, Jian-Hua Mao, et al.
Genome Research|September 28, 2011
Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundantHaya H Al-Balool, David Weber, Yilei Liu, et al.
Cell Metabolism|May 14, 2013
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in miceWilliam L Holland, Andrew C Adams, Joseph T Brozinick, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 16, 2023
Neural Correlates of the p Factor in Adolescence: Cognitive Control With and Without Enhanced Positive Affective DemandsAnaïs M Rodriguez-Thompson, Adam Bryant Miller, Mark Wade, et al.
Diabetes|April 24, 2019
Modified UCN2 Peptide Acts as an Insulin Sensitizer in Skeletal Muscle of Obese MiceMelissa L Borg, Julie Massart, Milena Schönke, et al.
JTO Clinical and Research Reports|September 30, 2021
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted <i>Listeria monocytogenes</i>-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 StudiesJulie R Brahmer, Melissa L Johnson, Manuel Cobo, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2021
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancerCharles G Drake, Russell K Pachynski, Sumit K Subudhi, et al.
Cancer Research|January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung CancerJosephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Nature Communications|August 18, 2024
CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflictsLaura Curti, Sara Rohban, Nicola Bianchi, et al.
Molecular Carcinogenesis|August 28, 2015
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor developmentCassandra J Adams, Jennifer S Yu, Jian-Hua Mao, et al.
Genome Research|September 28, 2011
Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundantHaya H Al-Balool, David Weber, Yilei Liu, et al.
Cell Metabolism|May 14, 2013
An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in miceWilliam L Holland, Andrew C Adams, Joseph T Brozinick, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 16, 2023
Neural Correlates of the p Factor in Adolescence: Cognitive Control With and Without Enhanced Positive Affective DemandsAnaïs M Rodriguez-Thompson, Adam Bryant Miller, Mark Wade, et al.
Diabetes|April 24, 2019
Modified UCN2 Peptide Acts as an Insulin Sensitizer in Skeletal Muscle of Obese MiceMelissa L Borg, Julie Massart, Milena Schönke, et al.
JTO Clinical and Research Reports|September 30, 2021
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted <i>Listeria monocytogenes</i>-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 StudiesJulie R Brahmer, Melissa L Johnson, Manuel Cobo, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2021
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancerCharles G Drake, Russell K Pachynski, Sumit K Subudhi, et al.
Cancer Research|January 30, 2020
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung CancerJosephine A Taverna, Chia-Nung Hung, Daniel T DeArmond, et al.
Pageof 15